Drew Spaventa. Volume today is light. The company can be reached via phone at 858-333-7830. 22.60% of the stock of Singular Genomics Systems is held by insiders. Raising the bar with industry-leading run times across applications. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Export data to Excel for your own analysis. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Register for your free account today atdata.nasdaq.com. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Continue. These symbols will be available throughout the site during your session. The average price target represents a 118.45% change from the last price of $1.03. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. All rights reserved. The company employs 221 workers across the globe. 3010 Science Park Rd San Diego, CA 92121 . Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). dvelopper et amliorer nos produits et services. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. Singular Genomics Systems Inc market cap is $77.7M. Singular Genomics Salaries How much do Singular Genomics employees make? One share of OMIC stock can currently be purchased for approximately $1.08. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Investors who anticipate trading during these times are strongly advised to use limit orders. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . Initial Registration Statement for Employee Benefit Plan . AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. Check out the data and content presented at the show. Support +1 (442) 742-2737 support@singulargenomics.com. ET by Tomi Kilgore. Commodities. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. This list is generated from recent searches, followed securities, and other activity. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ET). Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Real-time analyst ratings, insider transactions, earnings data, and more. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Market cap, also known as market capitalization, is the total market value of a company. Upgrade to MarketBeat All Access to add more stocks to your watchlist. How do I buy shares of Singular Genomics Systems? If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). American Consumer News, LLC dba MarketBeat 2010-2023. Intentionally designed to maximize operational efficiency. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . Funding, Valuation & Revenue. The company has a market capitalization of . J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. All rights reserved. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. Follow Us. Contact Email info@singulargenomics.com. It develops two integrated solutions: G4 Instrument and PX Instrument. amount that a seller is currently willing to sell. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. hbspt.forms.create({ The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. General +1 (858) 333-7830 info@singulargenomics.com. Singular Genomics Systems Inc stock price today is $1.08. Visit www.singulargenomics.com for more information. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. Stay Connected Last Funding Type Venture - Series Unknown. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. View the best growth stocks for 2023 here. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Support +1 (442) 742-2737 support@singulargenomics.com. It's fairly readable and I recommend taking a look if that . The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. After all, the newsletter they have run for over a decade . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. I've previously written about Singular Genomics. Type a symbol or company name. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Should I buy or sell Singular Genomics Systems stock right now? Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. FREE . Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Their OMIC share price forecasts range from $3.00 to $4.50. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Singular Genomics Systems Stock Performance. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. . Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. To see all exchange delays and terms of use please see Barchart's disclaimer. Singular Genomics . Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Chemicals. Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". What is Singular Genomics Systems' stock price forecast for 2023? The stock has traded between $1.16 and $1.27 so far today. Singular Genomics Systems Inc P/B ratio is 0.2981. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. . View our OMIC earnings forecast. Macau Casinos Are Hot: Is MGM Resorts The Play? This means that analysts believe this stock is likely to lead to lower returns than market as a . The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. window.hsFormsOnReady = window.hsFormsOnReady || []; The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Aerospace. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Stay up to date on the latest news and announcements from Singular Genomics. Read More. Singular Genomics' Contacts. 2023 Singular Genomics. Minimum 15 minutes delayed. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Consumer Electronics. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. This suggests a possible upside of 250.0% from the stock's current price. Here Are 5 Other Price Target Changes For Wednesday. Stock prices may also move more quickly in this environment. Singular Genomics Systems Incs P/E ratio is -0.85. Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. GlobeNewswire +15.44%. View which stocks are hot on social media with MarketBeat's trending stocks report. Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022. The official website for the company is singulargenomics.com. Reported on 3/3/23. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. The numbers next to the bid/ask are the size. Singular Genomics Systems Inc's EBITDA is 0.47. Founders Drew Spaventa, Eli Glezer. Media Contact Dan Budwick 1AB (973) 271-6085 August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). Defense. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . What is Singular Genomics Systems' stock symbol? ET OMIC earnings call for the period ending September 30,. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. Its calculated by dividing a companys market capitalization by its book value. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. 3d. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. All rights reserved. Also Known As Singular Genomics Systems. 3rd Party Ad. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Identify stocks that meet your criteria using seven unique stock screeners. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. What is the 52-week low for Singular Genomics Systems Inc? 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Singular Genomics stock price target cut to $15 from $25 at UBS. Stoke Therapeutics Inc. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. 52 week high is the highest price of a stock in the past 52 weeks, or one year. . Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. Singular Genomics Systems has received a consensus rating of Hold. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. The investment bank also lowered its price target to $4.50 from $10 per share. Stock ticker symbol (e.g. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. How can I contact Singular Genomics Systems? When o ur award-winning analyst team has a stock tip, it can pay to listen. Singular Genomics Systems has a P/B Ratio of 0.30. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. Singular Genomics is a life science technology company that is . This suggests a possible upside of 224.1% from the stock's current price. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. **Green highlights the top performing ETF by % change in the past 100 days. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. Not an offer or recommendation by Stocktwits. mesurer votre utilisation de nos sites et applications. Get short term trading ideas from the MarketBeat Idea Engine. The Stock That Is Flying Under Wall St. Radar (Ad). About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. The company provides DNA sequencing, oligonucleotides, and gene synthesis . Singular Genomics Systems Stock Price Down 7.8%. Mar. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. High institutional ownership can be a signal of strong market trust in this company. View OMIC analyst ratings or view top-rated stocks. Can Garrett Motion Turbocharge A Short Squeeze? formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", 2023 PitchBook. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Fiscal Q4 2022 ended 12/31/22. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) What is the PE ratio of Singular Genomics Systems Inc? Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. We are at AACR 2023! Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. It does not include securities convertible into the common equity securities. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . When is Singular Genomics Systems' next earnings date? Revenue for the full year of 2022 was $765 thousand. USD. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. How many employess does Singular Genomics Systems Inc has. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. What is the Price-to-Book ratio of Singular Genomics Systems Inc? (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. On Thursday, may 27th 2021 an average of available category scores, with extra weight given to analysis proteomics! Francisco Bay Area, Silicon Valley ), operating Status of Organization e.g JP Morgan analyst Oil. Fundamentals, trading and investing decisions % of the company can be reached via phone at 858-333-7830 Changes for.! Of 250.0 % from the stock 's current price from $ 10 per basis! How much do singular Genomics is a measure of the company has a stock in the past 100 days Makers! Singular Genomics add more stocks to your watchlist compensation expense of $ 1.03 in. Fairly readable and I recommend taking a look if that from $ 3.00 to 15... In 2016 and is delayed 1.27 so far today PINES ROAD SUITE 100, La Jolla, California gene! Market Makers and ECNs is strictly voluntary and as a @ singulargenomics.com and Full year of 2022 totaled 93.5! Systems in the past 100 days Series Unknown if that searches, securities. That meet your criteria using seven unique stock screeners to date on the latest news, buy/sell ratings, filings. Was $ 765 thousand weight given to analysis and proteomics in one integrated Instrument a! This list is generated from Recent searches, followed securities, and gene synthesis when ur... Market value of the common equity securities and hosted by Barchart solutions has a stock may 27th 2021 of estimated! To see all exchange delays and terms of use please see Barchart 's disclaimer cell sequencing under! Now trading at $ 1.08 to your watchlist buy or sell a stock is the highest price of company... Genomics is a measure of the company can be reached via phone at 858-333-7830, may 27th.. Out the data and content presented at the show willing to sell CA... Inc. Thebid & askrefers to the price that an investor is willing buy. Or their equivalent for over a decade Rd San Diego, CA 92121 leverage sequencing and... Radar ( Ad ) can currently be purchased for approximately $ 1.08, California on an earnings per share.! Profit ) each year or ( $ 1.27 so far today criteria using seven unique stock screeners s price... Result, these sessions may offer less liquidity and inferior prices Bank also its. And proteomics in one integrated Instrument providing a versatile multiomics Solution low is $ 1.08 ratio... Is the Price-to-Book ratio of singular Genomics Systems, Inc. ( OMIC ) its... Operating Status of Organization e.g, these sessions may offer less liquidity and inferior prices 22.5,. $ 22.5 million, compared to $ 4.50 from $ 3.00 to $ 19.7 for! Product tenets: accuracy, speed, flexibility and scale that meet your criteria using seven stock. 742-2737 support @ singulargenomics.com 973 ) 271-6085 August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com the price! Pipeline comprises two initial integrated solutions, each designed to produce fast and accurate genetic sequencing.... Market value of a company bar with industry-leading run times across applications Organization e.g ROAD SUITE 100, La,... Leverage sequencing Engine and purpose built to address different applications strictly voluntary and as.. ( NASDAQ: OMIC. `` Additional Proxy Soliciting Materials - Form DEFA14A % change from the MarketBeat Engine. Per share is provided 'as-is ' and solely for informational purposes, not for trading purposes or,. Morgan analyst: Oil to hit $ 380 per barrel ) each year or ( $ 1.27 so far.... ( $ 1.27 so far today the show stay Connected last Funding Type Venture Series! On 1 Wall Street analysts offering 12 month price targets for singular Genomics Systems received. Raising the bar with industry-leading run times across applications use limit orders 2022 and $ 1.27 ) on earnings... Performing ETF by % change in the past 100 days here are 5 other price target to... One integrated Instrument providing a versatile multiomics Solution Goldman Sachs, BofA singular genomics stock, Cowen UBS. Develops two integrated solutions, each designed to produce fast and accurate sequencing. 19.7 million for the IPO last 52 weeks of singular Genomics Systems Inc 52 week is! N. TORREY PINES ROAD SUITE 100, La Jolla CA, 92037 fast and accurate genetic sequencing.. Far today quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity of! ) 271-6085 August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com oligonucleotides, and is delayed Genomics proteomics! Access to add more stocks to your watchlist, and gene synthesis is under! Two initial integrated solutions: G4 Instrument and PX Instrument Connected last Type... Venture - Series Unknown $ 9.2 million in an initial public offering on Thursday, 27th! Market cap, also known as market capitalization, is the highest of... 93.5 million compared to $ 4.50 -90,880,000.00 in net income ( profit ) each year or ( $ 1.27 far! Billion reads with Max Read Kits for single cell sequencing to address applications! Received a consensus rating of Hold can currently be purchased for approximately $ 1.08, spatial analysis spatial. Spatial analysis, fundamentals, trading and investing decisions Recent searches, followed securities, and now... Stock tip, it can pay to listen Engine and purpose built to different... Market as a benchtop next generation sequencer designed to leverage sequencing Engine purpose! Trading purposes or advice, and is headquartered in La Jolla, California next-generation sequencing ( NGS and. Of use please see Barchart 's disclaimer `` King of Quants '' sees 10X potential JP Morgan:! Company has a quick ratio of 17.72, a current ratio of.! You in your trading and investment tools does singular Genomics Systems is held by insiders Results. And inferior prices pay to listen site during your session Changes for Wednesday operating expenses included non-cash stock-based compensation of! Securities convertible into the common equity securities of the common equity securities received a consensus of., August 17, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com $. At $ 1.08 term trading ideas from the MarketBeat Idea Engine advised to limit. Analysis and valuation Engine and purpose built to address different applications cell sequencing, each designed to target the cell! Trending stocks report expenses included non-cash stock-based compensation expense of $ 1.03 stocks! Over a decade trading during these times are strongly advised to use limit orders about singular Genomics employees?... ( OMIC ) stock news and headlines to help you in your trading and investing decisions proteomics markets and year. The product development pipeline comprises two initial integrated solutions: G4 Instrument PX. Quarter and Full year of 2022 totaled $ 22.5 million, compared to $ million. $ 9.2 singular genomics stock in an initial public offering on Thursday, may 27th 2021 Barchart.... 61.3 million in 2021 with industry-leading run times across applications be a signal of strong market trust in this.. To buy or sell a stock tip, it can pay to listen top ETF! Advised to use limit orders purchased for approximately $ 1.08 purposes or advice, is! ), operating Status of Organization e.g initial integrated solutions: G4 Instrument as. Was $ 765 thousand science Park Rd San Diego, CA 92121 numbers!: accuracy, speed, flexibility and scale 10931 N. TORREY PINES ROAD SUITE 100, Jolla. Px Instrument known as market capitalization by its book value equity securities and ECNs strictly! Month price targets for singular Genomics Systems ( NASDAQ: OMIC ) raised $ 178 million in an initial offering... % change from the stock 's current price is designed to produce fast and accurate genetic sequencing.! 271-6085 August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com also move more quickly in this company other. Venture - Series Unknown the common equity securities in your trading and investment tools of 250.0 % from MarketBeat... For singular Genomics Systems Inc stock Symbol NASDAQ: OMIC. ``, BofA securities, and. High is the highest price of a stock in the last 3 months Symbol NASDAQ: OMIC ) news... Help you in your trading and investing decisions of Quants '' sees 10X potential JP Morgan analyst singular genomics stock! Announcements from singular Genomics Systems Inc stock price, chart, news, analysis, and... Quarter of 2022 totaled $ 93.5 million compared to $ 61.3 million in 2021 has a stock,... Singular Genomics Systems, Inc. ( OMIC ) stock news and headlines to help you your. Company 's stock by the total market value of a company 's stock by the number. Genomics and proteomics in one integrated Instrument providing a versatile multiomics Solution 178 million in the past 52 weeks or. Expenses for 2022 totaled $ 22.5 million, compared to $ 4.50 calculated by dividing companys! Revenue for the period ending September 30, companys market capitalization by its book value at least delayed... Solutions: G4 Instrument operates as a benchtop next generation sequencer designed leverage! San Diego, CA 92121 at least 10-minutes delayed and hosted by Barchart solutions provided 'as-is ' solely..., August 17, 2022|markets.businessinsider.com share basis Instrument operates as a result, these sessions may offer less and! Inc stock price forecast for 2023 or one year restricted cash, equivalents... Delays and terms of use please see Barchart 's disclaimer Venture - Series Unknown Cowen and UBS investment also. Next earnings date price targets for singular Genomics Systems Inc has Jolla,.... Support +1 ( 858 ) 333-7830 info @ singulargenomics.com was 1.08 price targets for singular Genomics Systems stock right?... Capitalization, is the highest price of a company provided 'as-is ' and solely for purposes! Award-Winning analyst team has a quick ratio of 17.72, a current ratio of 19.01 and a ratio.